82 results
8-K
EX-99.1
REVB
Revelation Biosciences Inc
22 Mar 24
Results of Operations and Financial Condition
4:22pm
.
REVELATION BIOSCIENCES, INC.
Consolidated Statements of Operations
Three Months Ended
December 31,
Year Ended
December 31,
Operating expenses:
Research … and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense):
Change in fair value of warrant liability
424B3
REVB
Revelation Biosciences Inc
2 Feb 24
Prospectus supplement
4:06pm
research and development activities, including early clinical study, and providing general and administrative support for these operations. Investment … from product sales to date and we continue to incur significant research and development and other expenses related to our ongoing operations. We have
8-K
EX-99.1
wufjdt6n a4vya
13 Nov 23
Results of Operations and Financial Condition
4:30pm
8-K
EX-99.1
1pecr
11 Aug 23
Results of Operations and Financial Condition
4:30pm
8-K
EX-99.1
sdn 0shh6j39lz7bo
22 May 23
Results of Operations and Financial Condition
1:22pm
8-K
EX-99.1
xs7x7p
3 Apr 23
Results of Operations and Financial Condition
4:33pm